<?xml version='1.0' encoding='utf-8'?>
<document id="21274983"><sentence text="Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)."><entity charOffset="53-67" id="DDI-PubMed.21274983.s1.e0" text="gadoxetic acid" /><entity charOffset="72-84" id="DDI-PubMed.21274983.s1.e1" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.21274983.s1.e0" e2="DDI-PubMed.21274983.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21274983.s1.e0" e2="DDI-PubMed.21274983.s1.e1" /></sentence><sentence text="To evaluate if erythromycin compromises liver-specific enhancement of gadoxetic acid; both compounds competing in organic anion transporting peptides (OATP) -mediated hepatocytic uptake"><entity charOffset="15-27" id="DDI-PubMed.21274983.s2.e0" text="erythromycin" /><entity charOffset="70-84" id="DDI-PubMed.21274983.s2.e1" text="gadoxetic acid" /><pair ddi="false" e1="DDI-PubMed.21274983.s2.e0" e2="DDI-PubMed.21274983.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21274983.s2.e0" e2="DDI-PubMed.21274983.s2.e1" /></sentence><sentence text="" /><sentence text="The study was approved by institutional review board" /><sentence text=" Twelve healthy subjects (nine men, three woman; mean age, 38" /><sentence text="7 years) were examined twice by MR imaging with prior administration of NaCl solution (placebo) or 1000 mg of erythromycin following a randomized sequence"><entity charOffset="72-76" id="DDI-PubMed.21274983.s6.e0" text="NaCl" /><entity charOffset="110-122" id="DDI-PubMed.21274983.s6.e1" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.21274983.s6.e0" e2="DDI-PubMed.21274983.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21274983.s6.e0" e2="DDI-PubMed.21274983.s6.e1" /></sentence><sentence text=" Gadoxetic acid (0"><entity charOffset="1-15" id="DDI-PubMed.21274983.s7.e0" text="Gadoxetic acid" /></sentence><sentence text="025 mmol/kg body weight) was administered 15 min after the end of infusions" /><sentence text=" Pre- and 20 min postcontrast two-dimensional gradient-recalled-echo sequences were acquired" /><sentence text=" Relative enhancements of liver parenchyma and ratio of means were calculated from signal intensity measurements" /><sentence text=" Plasma levels of gadoxetic acid and erythromycin were determined and given in geometric means and coefficients of variation (CV)"><entity charOffset="18-32" id="DDI-PubMed.21274983.s11.e0" text="gadoxetic acid" /><entity charOffset="37-49" id="DDI-PubMed.21274983.s11.e1" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.21274983.s11.e0" e2="DDI-PubMed.21274983.s11.e0" /><pair ddi="false" e1="DDI-PubMed.21274983.s11.e0" e2="DDI-PubMed.21274983.s11.e1" /></sentence><sentence text="" /><sentence text="Concentration of erythromycin directly after end of infusion was 13"><entity charOffset="17-29" id="DDI-PubMed.21274983.s13.e0" text="erythromycin" /></sentence><sentence text="9 mg/L (CV 14" /><sentence text="9%)" /><sentence text=" Gadolinium plasma concentrations 5 min after gadoxetic acid administration were 138"><entity charOffset="1-11" id="DDI-PubMed.21274983.s16.e0" text="Gadolinium" /><entity charOffset="46-60" id="DDI-PubMed.21274983.s16.e1" text="gadoxetic acid" /><pair ddi="false" e1="DDI-PubMed.21274983.s16.e0" e2="DDI-PubMed.21274983.s16.e0" /><pair ddi="false" e1="DDI-PubMed.21274983.s16.e0" e2="DDI-PubMed.21274983.s16.e1" /></sentence><sentence text="7 μmol/L (CV 20" /><sentence text="4%) after erythromycin infusion and 129"><entity charOffset="10-22" id="DDI-PubMed.21274983.s18.e0" text="erythromycin" /></sentence><sentence text="6 μmol/L (CV 22" /><sentence text="8%) after placebo" /><sentence text=" Mean relative enhancements of liver parenchyma were 88" /><sentence text="1 (SD 24" /><sentence text="9%) after erythromycin infusion and 92"><entity charOffset="10-22" id="DDI-PubMed.21274983.s23.e0" text="erythromycin" /></sentence><sentence text="6 (SD 17" /><sentence text="9%) after placebo" /><sentence text=" Ratio of relative enhancements was 0" /><sentence text="951 (95% confidence interval, 0" /><sentence text="833; 1" /><sentence text="061; statistically not significant)" /><sentence text="" /><sentence text="Coadministration of erythromycin has no effect on gadoxetic acid enhanced liver MR imaging"><entity charOffset="20-32" id="DDI-PubMed.21274983.s31.e0" text="erythromycin" /><entity charOffset="50-64" id="DDI-PubMed.21274983.s31.e1" text="gadoxetic acid" /><pair ddi="false" e1="DDI-PubMed.21274983.s31.e0" e2="DDI-PubMed.21274983.s31.e0" /><pair ddi="false" e1="DDI-PubMed.21274983.s31.e0" e2="DDI-PubMed.21274983.s31.e1" /></sentence><sentence text="" /></document>